Ignite Creation Date:
2024-05-06 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 12:44 PM
Study NCT ID:
NCT03505008
Status:
UNKNOWN
Last Update Posted:
2021-09-01
First Post:
2018-04-16
Brief Title:
Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan South Korea and Taiwan
Sponsor:
Keio University
Organization:
Keio University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-18
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-04-16
First Submit QC Date:
April 16 2018
Study First Post Date:
2018-04-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-31
Last Update Post Date:
2021-09-01
Last Update Post Date Type:
ACTUAL